Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127220291 | 12722029 | 1 | I | 20160602 | 20160907 | 20160907 | PER | US-DRREDDYS-DRL/USA/16/0080347 | DR REDDYS | 47.00 | YR | F | Y | 90.72000 | KG | 20160907 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127220291 | 12722029 | 1 | PS | Atorvastatin Tablets 80 mg (202357) | ATORVASTATIN | 1 | Oral | N | U | UNKNOWN | 202357 | 80 | MG | TABLET | QD | ||||
| 127220291 | 12722029 | 2 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 127220291 | 12722029 | 3 | C | PHENYTOIN. | PHENYTOIN | 1 | Unknown | 0 | |||||||||||
| 127220291 | 12722029 | 4 | C | CARVEDILOL. | CARVEDILOL | 1 | Unknown | 0 | |||||||||||
| 127220291 | 12722029 | 5 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 0 | |||||||||||
| 127220291 | 12722029 | 6 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | Unknown | 0 | |||||||||||
| 127220291 | 12722029 | 7 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127220291 | 12722029 | 1 | Hyperlipidaemia |
| 127220291 | 12722029 | 2 | Hypertension |
| 127220291 | 12722029 | 3 | Product used for unknown indication |
| 127220291 | 12722029 | 4 | Product used for unknown indication |
| 127220291 | 12722029 | 5 | Product used for unknown indication |
| 127220291 | 12722029 | 6 | Product used for unknown indication |
| 127220291 | 12722029 | 7 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127220291 | 12722029 | Breast disorder | |
| 127220291 | 12722029 | Breast pain | |
| 127220291 | 12722029 | Hepatic enzyme increased | |
| 127220291 | 12722029 | Memory impairment | |
| 127220291 | 12722029 | Muscle spasms | |
| 127220291 | 12722029 | Paraesthesia | |
| 127220291 | 12722029 | Peripheral swelling | |
| 127220291 | 12722029 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127220291 | 12722029 | 1 | 20131101 | 20160601 | 0 | |
| 127220291 | 12722029 | 2 | 2012 | 201605 | 0 |